Back to Industry News
General
Australia Invests $13.6M to Strengthen Clinical Trials; AusBiotech Applauds
Summary generated with AI, editor-reviewed
Heartspace News Desk
•Source: Biotech Dispatch
Photo by National Cancer Institute on Unsplash
TL;DR
The Australian life sciences sector will receive $13.6 million from the Albanese Government to improve national health and medical research. This investment will establish a National One Stop Shop for clinical trials, create national standard operating procedures, and implement the National Clinical Trials Governance Framework nationwide.
Stay updated on stories like this
Key takeaways
- The Australian life sciences sector is poised to receive a significant boost with a $13
- 6 million investment from the Albanese Government
- According to Biotech Dispatch, this funding aims to advance national health and medical research reforms by supporting the creation of a National One Stop Shop for clinical trials, developing national standard operating procedures, and implementing the National Clinical Trials Governance Framework nationwide
The Australian life sciences sector is poised to receive a significant boost with a $13.6 million investment from the Albanese Government. According to Biotech Dispatch, this funding aims to advance national health and medical research reforms by supporting the creation of a National One Stop Shop for clinical trials, developing national standard operating procedures, and implementing the National Clinical Trials Governance Framework nationwide.
AusBiotech CEO Rebekah Cassidy hailed the reform as a "once-in-a-generation opportunity." However, she emphasized the importance of a unified, whole-of-government strategy for the life sciences industry, pointing out that current policy oversight is fragmented across nine government portfolios.
Related Topics
clinical trialsAustraliaAusBiotechfundinglife sciencesresearchgovernment investment
Never miss stories like this